Cargando…
Will COVID-19 vaccine equity be possible in India?
Autor principal: | Mathivathanan, Kanagavalli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295011/ https://www.ncbi.nlm.nih.gov/pubmed/34330556 http://dx.doi.org/10.1016/j.vaccine.2021.07.049 |
Ejemplares similares
-
Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination
por: Franco-Paredes, Carlos, et al.
Publicado: (2021) -
Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?
por: Okereke, Melody
Publicado: (2021) -
Response to Letter to the Editor by Ish et al. entitled ‘COVID-19 vaccine equity—the need of the hour’
por: Maclean, P, et al.
Publicado: (2022) -
Dengue After COVID-19 Vaccination: Possible and Might be
Missed
por: Kebayoon, Amnuay, et al.
Publicado: (2021) -
COVID-19 vaccination drive in India – Beginning of the end
por: Bansal, Rohit, et al.
Publicado: (2021)